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To The Editor,
We  followed  with  interest  the  recent  debate  ignited  by
several  commentaries  on  Takotsubo  Syndrome  (TTS),
adrenergic  activation  in  mood  disorder  patients,  and  the
associated  clinical  and  public  health  implications  appraised
both in the Journal  of  Clinical  Practice and Epidemiology in
Mental  Health  (CPEMH)  [1  -  4]  and  in  other  peer-reviewed
sources  [5,  6].  An  important  issue  deals  with  the  putative
connection  between  Electroconvulsive  Therapy  (ECT)  and
subsequent  TTS.
A burgeoning of case reports [7] published since the year
2009 [8], highlight the not-that infrequent occurrence of TTS
soon after the delivery of a course of ECT.
In general, case reports, namely the detailed report of the
symptoms,  signs,  diagnosis,  treatment,  and  follow-up  of  an
individual patient, or (n=1, meaning one unique patient), and
case series (up to n=10) represent timely, and essential study
design  in  advancing  medical  and  scientific  knowledge,
especially of rare diseases in the absence of systematic chart-
review [9]. The European Union definition of a rare disease is
one  that  affects  fewer  than  5  in  10,000  people  (https://
www.eurordis.org/about-rare-diseases).  However,  no  consen-
sus exists about “how rare” a disease should be considered a
“rare”  one.  This  is  particularly  true  for  medical  fields  other
than genetics, or whenever the “rare” condition is nonetheless
life-threatening.
In  recent  years,  case  reports  came  under  scrutiny  and
disfavor among some in the scientific publishing community,
and case studies are frequently relegated to the lowest rank of
the hierarchy of study design. Carey documented that 32% of
journals do not publish case reports, and another 36% publish
them in a modified format [10]. However, prestigious journals,
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including the  New England Medical  Journals,  the  Lancet,  or
those  published  by  BioMed  Central  (with  ad-hoc  editorial
destinations),  to  name  a  few,  continue  to  publish  even  case
reports [11]. CPEMH likewise does.
Generally  speaking,  case  reports  are  prone  to  both
“confounding  bias”  (factors,  which  we  are  unaware  of  may
influence the observed outcomes), “chance”, and “causation”
nexus  (inferred  in  place  of  mere  report  of  “association”
between  two events,  e.g.  ECT and  subsequent  occurrence  of
TTS).
However,  as  remarked above,  the  “rarity”  of  a  condition
remains  an  elusive  concept,  primarily  when  it  is  associated
with  major  or  life-threatening  outcomes,  as  is  the  case  with
TTS.  Also,  multiple  independent  case  reports,  published
consistently over a period of a decade or longer, coming from
clinicians  based  in  different  geographic  regions  reasonably
deserve attention; especially considering that “more rigorous”
controlled  clinical  trials  almost  invariably  exclude  the  most
severe cases (of mood disorders, in this context) per protocol,
thus  undermining  the  chances  of  occurrence  of  infrequent
events  among  the  most  sensitive  individuals  (read  TTS
outcome after ECT). Given the self-limiting dissemination of
case-reports, and the reluctance of many journals to consider
them, especially after previous similar reports on the matter, it
cannot be excluded that the “association” (no causal inference
made in contrast to “causation”) between TTS and ECT is even
more frequently observed in clinical settings than appraised in
the literature.
Several  studies  have  now established  a  close  association
between  mood  disorders  and  cardiovascular  disorders  in
general  [12,  13],  and  TTS  in  particular  [4],  suggesting  a
rationale  for  a  possible  “vulnerable”  condition  for  TTS,
independently of ECT, in people with depressive and bipolar
disorders. However, the pathogenetic hypotheses about the role
of  norepinephrine  activation  in  TTS [2,  14]  suggest  a  causal
link between ECT and TTS, given the noradrenergic increase
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following  electroconvulsive  therapy  [15].  Such  claims
reinforce  the  suspicion  of  a  possible  causal  trigger  between
ECT and TTS that  may occur  among vulnerable  individuals.
Given the uneasiness of the diagnosis of TTS [14], it cannot be
excluded that, in the absence of careful cardiologic workup, the
TTS  may  have  also  been  misunderstood  or  underdiagnosed,
even among those patients exposed to ECT.
Several factors may inflate the rates of underdiagnosis of
previous TTS in patients with severe mood disorders (as those
that  underwent  ECT);  especially  considering  that  the
consequences of TTS could be better-observed long-term, with
rates  of  long-term  mortality  among  TTS  patients  exceeding
those  expected  in  patients  with  ST-Elevation  Myocardial
Infarction (STEMI) [16]. The mortality rates seen among TTS
patients  are  further  inflated  among  those  individuals  whose
severe mood disorders - often requiring intense ECT sessions
[17]  -  already  pose  a  significant  mortality  risk  due  to
cardiovascular  diseases  [18].
In conclusion, we congratulate the Editorial Board of the
Journal of CPEMH for posing emphasis even on single-patient
reports  about  the  intriguing,  and  clinically  burdensome,
plausible  association  between  ECT  and  TTS,  and  we  really
hope that further research attention will be given to the topic by
implementation of systematic registries and methodologically-
rigorous research on the matter.
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